2-({5-[(cyclohexylcarbamoyl)amino]-1,3,4-thiadiazol-2-yl}sulfanyl)-N-(5-methyl-1,2-oxazol-3-yl)acetamide结构式
|
常用名 | 2-({5-[(cyclohexylcarbamoyl)amino]-1,3,4-thiadiazol-2-yl}sulfanyl)-N-(5-methyl-1,2-oxazol-3-yl)acetamide | 英文名 | 2-({5-[(cyclohexylcarbamoyl)amino]-1,3,4-thiadiazol-2-yl}sulfanyl)-N-(5-methyl-1,2-oxazol-3-yl)acetamide |
|---|---|---|---|---|
| CAS号 | 946216-72-4 | 分子量 | 396.5 | |
| 密度 | N/A | 沸点 | N/A | |
| 分子式 | C15H20N6O3S2 | 熔点 | N/A | |
| MSDS | N/A | 闪点 | N/A |
| 英文名 | 2-({5-[(cyclohexylcarbamoyl)amino]-1,3,4-thiadiazol-2-yl}sulfanyl)-N-(5-methyl-1,2-oxazol-3-yl)acetamide |
|---|
| 分子式 | C15H20N6O3S2 |
|---|---|
| 分子量 | 396.5 |
| InChIKey | PXXXCXNJKKCVMB-UHFFFAOYSA-N |
| SMILES | CC1=CC(=NO1)NC(=O)CSC2=NN=C(S2)NC(=O)NC3CCCCC3 |
|
实验名称:High-throughput screen for inhibitors of the GIV GBA-motif interaction with Galpha-i ...
来源:ICCB-Longwood/NSRB Screening Facility, Harvard Medical School
External Id:HMS1303
|